121 related articles for article (PubMed ID: 38602342)
1. Current Status of Contralateral Prophylactic Mastectomy: Investigating Structural Racial Disparity.
Vadlakonda A; Curry J; Gao Z; Chervu N; Ali K; Lee H; Thompson CK; Benharash P
J Am Coll Surg; 2024 Apr; ():. PubMed ID: 38602342
[TBL] [Abstract][Full Text] [Related]
2. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.
Grimmer L; Liederbach E; Velasco J; Pesce C; Wang CH; Yao K
J Am Coll Surg; 2015 Jul; 221(1):187-96. PubMed ID: 26047763
[TBL] [Abstract][Full Text] [Related]
3. Trends in utilization of contralateral prophylactic mastectomy among different age, racial and ethnic groups.
Owusu-Brackett N; Aduwo J; Relation TS; Bhattacharyya O; Li Y; Fisher JL; Oppong BA
Gland Surg; 2023 Sep; 12(9):1224-1232. PubMed ID: 37842536
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients.
Bedrosian I; Hu CY; Chang GJ
J Natl Cancer Inst; 2010 Mar; 102(6):401-9. PubMed ID: 20185801
[TBL] [Abstract][Full Text] [Related]
5. Social and Clinical Determinants of Contralateral Prophylactic Mastectomy.
Hawley ST; Jagsi R; Morrow M; Janz NK; Hamilton A; Graff JJ; Katz SJ
JAMA Surg; 2014 Jun; 149(6):582-9. PubMed ID: 24849045
[TBL] [Abstract][Full Text] [Related]
6. Influence of Distance to Hospital and Insurance Status on the Rates of Contralateral Prophylactic Mastectomy, a National Cancer Data Base study.
Ward EP; Unkart JT; Bryant A; Murphy J; Blair SL
Ann Surg Oncol; 2017 Oct; 24(10):3038-3047. PubMed ID: 28766225
[TBL] [Abstract][Full Text] [Related]
7. Effect of rurality and travel distance on contralateral prophylactic mastectomy for unilateral breast cancer.
Wahlen MM; Lizarraga IM; Kahl AR; Zahnd WE; Eberth JM; Overholser L; Askelson N; Hirschey R; Yeager K; Nash S; Engelbart JM; Charlton ME
Cancer Causes Control; 2023 Dec; 34(Suppl 1):171-186. PubMed ID: 37095280
[TBL] [Abstract][Full Text] [Related]
8. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
[TBL] [Abstract][Full Text] [Related]
9. Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias.
Jatoi I; Parsons HM
Breast Cancer Res Treat; 2014 Nov; 148(2):389-96. PubMed ID: 25301088
[TBL] [Abstract][Full Text] [Related]
10. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
[TBL] [Abstract][Full Text] [Related]
11. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
[TBL] [Abstract][Full Text] [Related]
12. Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I-III unilateral breast cancer in the USA, 1998-2016.
Yang Y; Pan L; Shao Z
Breast Cancer Res Treat; 2021 Dec; 190(3):503-515. PubMed ID: 34554371
[TBL] [Abstract][Full Text] [Related]
13. Trends in use of contralateral prophylactic mastectomy by racial/ethnic group and ER/PR status among patients with breast cancer: A SEER population-based study.
Brown D; Shao S; Jatoi I; Shriver CD; Zhu K
Cancer Epidemiol; 2016 Jun; 42():24-31. PubMed ID: 26999400
[TBL] [Abstract][Full Text] [Related]
14. Socioeconomic Factors Associated with the Receipt of Contralateral Prophylactic Mastectomy in Women with Breast Cancer.
Jerome-D'Emilia B; Trinh H
J Womens Health (Larchmt); 2020 Feb; 29(2):220-229. PubMed ID: 30759049
[No Abstract] [Full Text] [Related]
15. Trends in Contralateral Prophylactic Mastectomy Utilization for Small Unilateral Breast Cancer.
Baskin AS; Wang T; Bredbeck BC; Sinco BR; Berlin NL; Dossett LA
J Surg Res; 2021 Jun; 262():71-84. PubMed ID: 33548676
[TBL] [Abstract][Full Text] [Related]
16. Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer.
Pesce C; Liederbach E; Wang C; Lapin B; Winchester DJ; Yao K
Ann Surg Oncol; 2014 Oct; 21(10):3231-9. PubMed ID: 25081341
[TBL] [Abstract][Full Text] [Related]
17. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
Pinell-White XA; Kolegraff K; Carlson GW
Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
[TBL] [Abstract][Full Text] [Related]
18. Predictors of contralateral prophylactic mastectomy in genetically high risk newly diagnosed breast cancer patients.
Tynan M; Peshkin BN; Isaacs C; Willey S; Valdimarsdottir HB; Nusbaum R; Hooker G; O'Neill SC; Jandorf L; Kelly SP; Heinzmann J; Kelleher S; Poggi E; Schwartz MD
Breast Cancer Res Treat; 2020 Feb; 180(1):177-185. PubMed ID: 31894446
[TBL] [Abstract][Full Text] [Related]
19. Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy.
Agarwal S; Pappas L; Matsen CB; Agarwal JP
Cancer Med; 2020 Nov; 9(21):8043-8052. PubMed ID: 32918537
[TBL] [Abstract][Full Text] [Related]
20. Survival analysis of contralateral prophylactic mastectomy: a question of selection bias.
Kruper L; Kauffmann RM; Smith DD; Nelson RA
Ann Surg Oncol; 2014 Oct; 21(11):3448-56. PubMed ID: 25047478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
